Order Article Reprints

Ren P, Chan T, Yang W-C, Frost M, Wang Y, Luke M, Kim M-J, Lionberger R, Zhang Y. Effect of the Similarity of Formulations and Excipients of Approved Generic Drug Products on In Vivo Bioequivalence for Putative Biopharmaceutics Classification System Class III Drugs. Pharmaceutics. 2023; 15(9):2366. https://doi.org/10.3390/pharmaceutics15092366

Ren, Ping, Theresa Chan, Wen-Cheng Yang, Mitchell Frost, Yan Wang, Markham Luke, Myong-Jin Kim, Robert Lionberger, and Yi Zhang. 2023. "Effect of the Similarity of Formulations and Excipients of Approved Generic Drug Products on In Vivo Bioequivalence for Putative Biopharmaceutics Classification System Class III Drugs" Pharmaceutics 15, no. 9: 2366. https://doi.org/10.3390/pharmaceutics15092366

Ren, P., Chan, T., Yang, W. -C., Frost, M., Wang, Y., Luke, M., Kim, M. -J., Lionberger, R., & Zhang, Y. (2023). Effect of the Similarity of Formulations and Excipients of Approved Generic Drug Products on In Vivo Bioequivalence for Putative Biopharmaceutics Classification System Class III Drugs. Pharmaceutics, 15(9), 2366. https://doi.org/10.3390/pharmaceutics15092366